CN118384862A - Protein-bound toxin adsorbent and preparation method and application thereof - Google Patents
Protein-bound toxin adsorbent and preparation method and application thereof Download PDFInfo
- Publication number
- CN118384862A CN118384862A CN202410483702.3A CN202410483702A CN118384862A CN 118384862 A CN118384862 A CN 118384862A CN 202410483702 A CN202410483702 A CN 202410483702A CN 118384862 A CN118384862 A CN 118384862A
- Authority
- CN
- China
- Prior art keywords
- protein
- polyethyleneimine
- styrene
- divinylbenzene
- ultra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 152
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 152
- 239000003053 toxin Substances 0.000 title claims abstract description 147
- 231100000765 toxin Toxicity 0.000 title claims abstract description 147
- 239000003463 adsorbent Substances 0.000 title claims abstract description 85
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 229920002873 Polyethylenimine Polymers 0.000 claims abstract description 127
- 239000011347 resin Substances 0.000 claims abstract description 119
- 229920005989 resin Polymers 0.000 claims abstract description 119
- 238000001179 sorption measurement Methods 0.000 claims abstract description 111
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims abstract description 110
- 239000003446 ligand Substances 0.000 claims abstract description 83
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims abstract description 14
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 9
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000005642 Oleic acid Substances 0.000 claims abstract description 9
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 9
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 8
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 8
- 229920001577 copolymer Polymers 0.000 claims description 98
- 238000006243 chemical reaction Methods 0.000 claims description 50
- 239000000243 solution Substances 0.000 claims description 35
- 238000004132 cross linking Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000005727 Friedel-Crafts reaction Methods 0.000 claims description 17
- 238000007265 chloromethylation reaction Methods 0.000 claims description 14
- 238000002791 soaking Methods 0.000 claims description 13
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 12
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- HRQGCQVOJVTVLU-UHFFFAOYSA-N bis(chloromethyl) ether Chemical compound ClCOCCl HRQGCQVOJVTVLU-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 8
- 239000012670 alkaline solution Substances 0.000 claims description 8
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 8
- 230000008081 blood perfusion Effects 0.000 claims description 6
- 239000011592 zinc chloride Substances 0.000 claims description 6
- 235000005074 zinc chloride Nutrition 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 230000027455 binding Effects 0.000 abstract description 16
- 230000009471 action Effects 0.000 abstract description 4
- 235000018102 proteins Nutrition 0.000 description 126
- 108700012359 toxins Proteins 0.000 description 124
- BXFFHSIDQOFMLE-UHFFFAOYSA-N indoxyl sulfate Chemical compound C1=CC=C2C(OS(=O)(=O)O)=CNC2=C1 BXFFHSIDQOFMLE-UHFFFAOYSA-N 0.000 description 30
- 108010088751 Albumins Proteins 0.000 description 20
- 102000009027 Albumins Human genes 0.000 description 20
- WGNAKZGUSRVWRH-UHFFFAOYSA-N p-cresol sulfate Chemical compound CC1=CC=C(OS(O)(=O)=O)C=C1 WGNAKZGUSRVWRH-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 16
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 239000003431 cross linking reagent Substances 0.000 description 10
- MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 229920002554 vinyl polymer Polymers 0.000 description 10
- 230000009881 electrostatic interaction Effects 0.000 description 9
- 239000002612 dispersion medium Substances 0.000 description 8
- 238000010557 suspension polymerization reaction Methods 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000003617 indole-3-acetic acid Substances 0.000 description 7
- 239000003999 initiator Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- WVYWICLMDOOCFB-UHFFFAOYSA-N 4-methyl-2-pentanol Chemical compound CC(C)CC(C)O WVYWICLMDOOCFB-UHFFFAOYSA-N 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 239000002270 dispersing agent Substances 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000003361 porogen Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000004342 Benzoyl peroxide Substances 0.000 description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 4
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 4
- 235000019400 benzoyl peroxide Nutrition 0.000 description 4
- 208000020832 chronic kidney disease Diseases 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 239000002441 uremic toxin Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WMCQWXZMVIETAO-UHFFFAOYSA-N 2-(2-carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic acid Chemical compound CCCC=1OC(CCC(O)=O)=C(C(O)=O)C=1C WMCQWXZMVIETAO-UHFFFAOYSA-N 0.000 description 2
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 2
- 208000037157 Azotemia Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- -1 equipment Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000010907 mechanical stirring Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ZJQIXGGEADDPQB-UHFFFAOYSA-N 1,2-bis(ethenyl)-3,4-dimethylbenzene Chemical group CC1=CC=C(C=C)C(C=C)=C1C ZJQIXGGEADDPQB-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- LBQJCDLKJGOHEA-UHFFFAOYSA-N 2-ethenylbut-3-enylbenzene Chemical compound C=CC(C=C)CC1=CC=CC=C1 LBQJCDLKJGOHEA-UHFFFAOYSA-N 0.000 description 1
- IFXDUNDBQDXPQZ-UHFFFAOYSA-N 2-methylbutan-2-yl 2-ethylhexaneperoxoate Chemical compound CCCCC(CC)C(=O)OOC(C)(C)CC IFXDUNDBQDXPQZ-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- BWDBEAQIHAEVLV-UHFFFAOYSA-N 6-methylheptan-1-ol Chemical compound CC(C)CCCCCO BWDBEAQIHAEVLV-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010023421 Kidney fibrosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 description 1
- XZKRXPZXQLARHH-UHFFFAOYSA-N buta-1,3-dienylbenzene Chemical compound C=CC=CC1=CC=CC=C1 XZKRXPZXQLARHH-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000001516 effect on protein Effects 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- CYGSXDXRHXMAOV-UHFFFAOYSA-N o-cresol hydrogen sulfate Chemical compound CC1=CC=CC=C1OS(O)(=O)=O CYGSXDXRHXMAOV-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- DBSDMAPJGHBWAL-UHFFFAOYSA-N penta-1,4-dien-3-ylbenzene Chemical compound C=CC(C=C)C1=CC=CC=C1 DBSDMAPJGHBWAL-UHFFFAOYSA-N 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- PJGSXYOJTGTZAV-UHFFFAOYSA-N pinacolone Chemical compound CC(=O)C(C)(C)C PJGSXYOJTGTZAV-UHFFFAOYSA-N 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- WYKYCHHWIJXDAO-UHFFFAOYSA-N tert-butyl 2-ethylhexaneperoxoate Chemical compound CCCCC(CC)C(=O)OOC(C)(C)C WYKYCHHWIJXDAO-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/261—Synthetic macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2325/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Derivatives of such polymers
- C08J2325/02—Homopolymers or copolymers of hydrocarbons
- C08J2325/04—Homopolymers or copolymers of styrene
- C08J2325/08—Copolymers of styrene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2379/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2361/00 - C08J2377/00
- C08J2379/02—Polyamines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2425/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Derivatives of such polymers
- C08J2425/02—Homopolymers or copolymers of hydrocarbons
- C08J2425/04—Homopolymers or copolymers of styrene
- C08J2425/08—Copolymers of styrene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2479/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2461/00 - C08J2477/00
- C08J2479/02—Polyamines
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Analytical Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及血液净化技术领域,具体而言,涉及一种蛋白结合毒素吸附剂及其制备方法和应用。The present invention relates to the technical field of blood purification, and in particular to a protein-bound toxin adsorbent and a preparation method and application thereof.
背景技术Background technique
尿毒症亦称终末期肾病,是慢性肾衰竭终末期的一种临床综合症。尿毒症患者体内约有两百多种物质的浓度比正常人要高,按照这些物质的生化性质主要分为三类:小分子水溶性溶质、中大分子毒素以及蛋白结合毒素三类。Uremia, also known as end-stage renal disease, is a clinical syndrome of the end stage of chronic renal failure. The concentration of more than 200 substances in the body of uremia patients is higher than that of normal people. According to the biochemical properties of these substances, they are mainly divided into three categories: small molecule water-soluble solutes, medium and large molecule toxins, and protein-bound toxins.
蛋白结合毒素的相对分子质量通常低于500,虽然蛋白质结合毒素的相对分子质量较小,但是蛋白质结合毒素易与血清蛋白结合,形成体积较大的蛋白结合形态,在尿毒症患者体内积累。蛋白质结合毒素在尿毒症患者体内的积累可损害各个系统的功能,引发并发症,并且有大量研究表明,蛋白结合毒素(PBUTs)参与了慢性肾衰竭的进展,与肾脏间质纤维化以及CKD心血管并发症密切相关。因此,有必要对尿毒症患者体内的蛋白质结合毒素进行清除。The relative molecular mass of protein-bound toxins is usually less than 500. Although the relative molecular mass of protein-bound toxins is small, protein-bound toxins are easily bound to serum proteins to form a larger protein-bound form, which accumulates in the body of uremic patients. The accumulation of protein-bound toxins in uremic patients can damage the functions of various systems and cause complications. A large number of studies have shown that protein-bound toxins (PBUTs) are involved in the progression of chronic renal failure and are closely related to renal interstitial fibrosis and cardiovascular complications of CKD. Therefore, it is necessary to remove protein-bound toxins in uremic patients.
传统的透析、滤过、透析滤过及高通量透析等技术对蛋白结合毒素的清除能力有限,现有技术中将吸附剂和透析器联用的血液净化系统,相比于传统的透析等血液净化方式,对蛋白结合毒素的清除能力有了显著的提高,但这些血液净化系统的对蛋白结合毒素的清除效果仍不理想。并且,现有的血液净化系统中的吸附剂对蛋白结合毒素的吸附缺少选择性。Traditional dialysis, filtration, diafiltration and high-flux dialysis technologies have limited ability to remove protein-bound toxins. The existing blood purification system that combines adsorbents and dialyzers has significantly improved the ability to remove protein-bound toxins compared to traditional blood purification methods such as dialysis, but the removal effect of these blood purification systems on protein-bound toxins is still unsatisfactory. In addition, the adsorbents in the existing blood purification systems lack selectivity for the adsorption of protein-bound toxins.
发明内容Summary of the invention
本发明旨在解决现有技术对蛋白结合毒素的清除效果较差的问题。The present invention aims to solve the problem that the prior art has poor effect in clearing protein-bound toxins.
为解决上述问题,本发明第一方面提供了一种蛋白结合毒素吸附剂,所述蛋白结合毒素吸附剂以超高交联苯乙烯-二乙烯苯树脂为载体,所述载体上固载有聚乙烯亚胺,所述聚乙烯亚胺连接有吸附配基,所述吸附配基包括α-甲基-4-(2-甲基丙基)苯乙酸、油酸和亚油酸中的至少一种。To solve the above problems, the first aspect of the present invention provides a protein-bound toxin adsorbent, which uses ultra-high cross-linked styrene-divinylbenzene resin as a carrier, on which polyethyleneimine is immobilized, and the polyethyleneimine is connected to an adsorption ligand, and the adsorption ligand includes at least one of α-methyl-4-(2-methylpropyl)phenylacetic acid, oleic acid and linoleic acid.
进一步地,所述超高交联苯乙烯-二乙烯苯树脂由低交联苯乙烯-二乙烯苯共聚物进行交联反应制得,所述聚乙烯亚胺在所述低交联苯乙烯-二乙烯苯共聚物交联反应过程中引入,所述吸附配基通过静电吸附连接至所述聚乙烯亚胺,所述聚乙烯亚胺的固载量范围为0.1mmol/g至1mmol/g。Furthermore, the ultra-high cross-linked styrene-divinylbenzene resin is prepared by cross-linking reaction of low-cross-linked styrene-divinylbenzene copolymer, the polyethyleneimine is introduced during the cross-linking reaction of the low-cross-linked styrene-divinylbenzene copolymer, the adsorption ligand is connected to the polyethyleneimine by electrostatic adsorption, and the solid loading range of the polyethyleneimine is 0.1mmol/g to 1mmol/g.
本发明第二方面提供了一种蛋白结合毒素吸附剂的制备方法,用于制备第一方面所述的蛋白结合毒素吸附剂,所述制备方法包括:The second aspect of the present invention provides a method for preparing a protein-bound toxin adsorbent, which is used to prepare the protein-bound toxin adsorbent described in the first aspect, and the preparation method comprises:
制备低交联苯乙烯-二乙烯苯共聚物;Preparation of low cross-linked styrene-divinylbenzene copolymers;
所述低交联苯乙烯-二乙烯苯共聚物进行交联反应,制备超高交联苯乙烯-二乙烯苯树脂,其中,所述超高交联苯乙烯-二乙烯苯树脂上固载有聚乙烯亚胺,所述聚乙烯亚胺在所述低交联苯乙烯-二乙烯苯共聚物交联反应过程中固载至所述超高交联苯乙烯-二乙烯苯树脂上;The low-crosslinked styrene-divinylbenzene copolymer undergoes a crosslinking reaction to prepare an ultra-high crosslinked styrene-divinylbenzene resin, wherein polyethyleneimine is immobilized on the ultra-high crosslinked styrene-divinylbenzene resin, and the polyethyleneimine is immobilized on the ultra-high crosslinked styrene-divinylbenzene resin during the crosslinking reaction of the low-crosslinked styrene-divinylbenzene copolymer;
将所述超高交联苯乙烯-二乙烯苯树脂浸泡至吸附配基溶液中,浸泡结束后,所述吸附配基连接至所述聚乙烯亚胺上,制得蛋白结合毒素吸附剂。The ultra-high cross-linked styrene-divinylbenzene resin is soaked in an adsorption ligand solution. After the soaking is completed, the adsorption ligand is connected to the polyethyleneimine to obtain a protein-bound toxin adsorbent.
进一步地,所述低交联苯乙烯-二乙烯苯共聚物进行交联反应,制备超高交联苯乙烯-二乙烯苯树脂,包括:Furthermore, the low cross-linked styrene-divinylbenzene copolymer is subjected to a cross-linking reaction to prepare an ultra-high cross-linked styrene-divinylbenzene resin, comprising:
将所述低交联苯乙烯-二乙烯苯共聚物进行氯甲基化反应,在氯甲基化反应过程中加入聚乙烯亚胺,制得含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物;The low-crosslinked styrene-divinylbenzene copolymer is subjected to a chloromethylation reaction, and polyethyleneimine is added during the chloromethylation reaction to obtain a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine;
将所述含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物进行傅克反应,制得超高交联苯乙烯-二乙烯苯树脂。The low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine is subjected to Friedel-Crafts reaction to obtain an ultra-high cross-linked styrene-divinylbenzene resin.
进一步地,所述将所述低交联苯乙烯-二乙烯苯共聚物进行氯甲基化反应,在氯甲基化反应过程中加入聚乙烯亚胺,制得含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物,包括:Further, the low cross-linked styrene-divinylbenzene copolymer is subjected to a chloromethylation reaction, and polyethyleneimine is added during the chloromethylation reaction to obtain a low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine, comprising:
将低交联苯乙烯-二乙烯苯共聚物加入二氯乙烷中溶胀后,将溶胀后的低交联苯乙烯-二乙烯苯共聚物、氯甲醚和无水三氯化铁在50℃至60℃下回流反应2h至4h后,升温至80℃至100℃继续回流反应5h至24h,同时,在升温的过程中加入聚乙烯亚胺进行反应,将所述聚乙烯亚胺引入至所述低交联苯乙烯-二乙烯苯共聚物上,制得含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物。After a low-crosslinked styrene-divinylbenzene copolymer is added to ethylene dichloride for swelling, the swollen low-crosslinked styrene-divinylbenzene copolymer, chloromethyl ether and anhydrous ferric chloride are refluxed at 50° C. to 60° C. for 2 h to 4 h, and then the temperature is raised to 80° C. to 100° C. for further reflux reaction for 5 h to 24 h. Meanwhile, polyethyleneimine is added during the heating process for reaction, and the polyethyleneimine is introduced into the low-crosslinked styrene-divinylbenzene copolymer to obtain a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine.
进一步地,所述低交联苯乙烯-二乙烯苯共聚物和所述氯甲醚的质量比为1:4至1:6,所述低交联苯乙烯-二乙烯苯共聚物和所述无水三氯化铁的质量比为1:0.5至1:1.5;所述低交联苯乙烯-二乙烯苯共聚物和所述聚乙烯亚胺的质量比为20:5至20:20。Furthermore, the mass ratio of the low-crosslinked styrene-divinylbenzene copolymer to the chloromethyl ether is 1:4 to 1:6, the mass ratio of the low-crosslinked styrene-divinylbenzene copolymer to the anhydrous ferric chloride is 1:0.5 to 1:1.5; the mass ratio of the low-crosslinked styrene-divinylbenzene copolymer to the polyethyleneimine is 20:5 to 20:20.
进一步地,所述将所述含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物进行傅克反应,制得超高交联苯乙烯-二乙烯苯树脂,包括:Furthermore, the low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine is subjected to a Friedel-Crafts reaction to obtain an ultra-high cross-linked styrene-divinylbenzene resin, comprising:
将所述含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物和硝基苯混合后,于35℃至45℃下静置4h至5h,再在搅拌下加入氯化锌,进行傅克反应,形成超高交联苯乙烯-二乙烯苯树脂,其中,所述傅克反应的温度为110℃至130℃,反应时间为8h至16h。The low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine and nitrobenzene are mixed, and then allowed to stand at 35° C. to 45° C. for 4 to 5 hours, and then zinc chloride is added under stirring to carry out Friedel-Crafts reaction to form an ultra-high crosslinked styrene-divinylbenzene resin, wherein the temperature of the Friedel-Crafts reaction is 110° C. to 130° C., and the reaction time is 8 to 16 hours.
进一步地,所述将所述超高交联苯乙烯-二乙烯苯树脂浸泡至吸附配基溶液中,浸泡结束后,所述吸附配基连接至所述聚乙烯亚胺上,制得蛋白结合毒素吸附剂,包括:Furthermore, the ultra-high cross-linked styrene-divinylbenzene resin is soaked in an adsorption ligand solution, and after the soaking, the adsorption ligand is connected to the polyethyleneimine to obtain a protein-bound toxin adsorbent, comprising:
将所述超高交联苯乙烯-二乙烯苯树脂浸泡至碱性溶液中,直至碱性溶液的pH值不变,得到转型后的超高交联苯乙烯-二乙烯苯树脂,将所述转型后的超高交联苯乙烯-二乙烯苯树脂清洗和干燥后,浸泡至吸附配基溶液中,浸泡结束后,清洗干净,制得蛋白结合毒素吸附剂,其中,所述吸附配基溶液中吸附配基的质量百分比为10%至40%。The ultra-high cross-linked styrene-divinylbenzene resin is immersed in an alkaline solution until the pH value of the alkaline solution remains unchanged to obtain the transformed ultra-high cross-linked styrene-divinylbenzene resin; the transformed ultra-high cross-linked styrene-divinylbenzene resin is washed and dried, and then immersed in an adsorption ligand solution; after the soaking, the resin is washed to obtain a protein-bound toxin adsorbent, wherein the mass percentage of the adsorption ligand in the adsorption ligand solution is 10% to 40%.
进一步地,采用去离子水清洗所述转型后的超高交联苯乙烯-二乙烯苯树脂,所述超高交联苯乙烯-二乙烯苯树脂在吸附配基中浸泡结束后,采用去离子水进行清洗。Furthermore, the transformed ultra-high cross-linked styrene-divinylbenzene resin is washed with deionized water. After the ultra-high cross-linked styrene-divinylbenzene resin is immersed in the adsorption ligand, it is washed with deionized water.
本发明第三方面提供了一种血液灌流器,包括如第一方面所述的蛋白结合毒素吸附剂,或者如第二方面所述的制备方法制得的蛋白结合毒素吸附剂。The third aspect of the present invention provides a blood perfusion device, comprising the protein-bound toxin adsorbent as described in the first aspect, or the protein-bound toxin adsorbent prepared by the preparation method as described in the second aspect.
本发明所述的蛋白结合毒素吸附剂,以超高交联苯乙烯-二乙烯苯树脂为载体,固载聚乙烯亚胺,聚乙烯亚胺连接有吸附配基,吸附配基带有负电荷,将该蛋白结合毒素吸附剂与血液接触,吸附配基从蛋白结合毒素吸附剂上脱落进入血液中,吸附配基具有与对甲酚硫酸盐和吲哚酚硫酸盐相同的白蛋白结合位点,其能够与蛋白结合毒素竞争吸附于白蛋白,且吸附配基与白蛋白的结合力强于蛋白结合毒素和白蛋白的结合力,使蛋白结合毒素从白蛋白上脱落,使蛋白结合毒素呈游离态,便于超高交联苯乙烯-二乙烯苯树脂和其上固载的聚乙烯亚胺对蛋白结合毒素进行吸附,提高对蛋白结合毒素的清除率;同时,以超高交联苯乙烯-二乙烯苯树脂为载体,超高交联苯乙烯-二乙烯苯树脂具有丰富的孔道结构,能够吸附尿毒症毒素中的中大分子物质和小分子蛋白结合毒素,超高交联苯乙烯-二乙烯苯树脂上固载的聚乙烯亚胺,带有正电荷,其能够与血液中的游离的蛋白结合毒素进行静电结合,对蛋白结合毒素进行清除。本发明所述的蛋白结合毒素吸附剂,通过吸附配基的作用使蛋白结合毒素呈游离态,同时通过超高交联苯乙烯-二乙烯苯树脂的吸附作用和聚乙烯亚胺的静电结合作用,对游离态的蛋白结合毒素进行清除,提高了对蛋白结合毒素的清除率。The protein-bound toxin adsorbent of the present invention uses ultra-high cross-linked styrene-divinylbenzene resin as a carrier, immobilizes polyethyleneimine, polyethyleneimine is connected with an adsorption ligand, the adsorption ligand has a negative charge, and the protein-bound toxin adsorbent is contacted with blood, and the adsorption ligand falls off the protein-bound toxin adsorbent and enters the blood. The adsorption ligand has the same albumin binding site as p-cresol sulfate and indoxyl sulfate, and can compete with protein-bound toxins for adsorption on albumin. The binding force between the adsorption ligand and albumin is stronger than the binding force between the protein-bound toxin and albumin, so that the protein-bound toxin falls off from the albumin, allowing the protein-bound toxin to be adsorbed on the albumin. The protein-bound toxin is in a free state, which is convenient for the ultra-high cross-linked styrene-divinylbenzene resin and the polyethyleneimine immobilized thereon to adsorb the protein-bound toxin, thereby improving the clearance rate of the protein-bound toxin; at the same time, with the ultra-high cross-linked styrene-divinylbenzene resin as the carrier, the ultra-high cross-linked styrene-divinylbenzene resin has a rich pore structure, which can adsorb medium and large molecular substances and small molecular protein-bound toxins in uremic toxins, and the polyethyleneimine immobilized on the ultra-high cross-linked styrene-divinylbenzene resin has a positive charge, which can electrostatically bind to the free protein-bound toxins in the blood to remove the protein-bound toxins. The protein-bound toxin adsorbent described in the present invention makes the protein-bound toxin in a free state through the action of the adsorption ligand, and at the same time, through the adsorption effect of the ultra-high cross-linked styrene-divinylbenzene resin and the electrostatic binding effect of the polyethyleneimine, the free protein-bound toxins are removed, thereby improving the clearance rate of the protein-bound toxins.
本发明所述的蛋白结合毒素吸附剂的制备方法,先通过悬浮聚合反应制备低交联苯乙烯-二乙烯苯共聚物,再通过低交联苯乙烯-二乙烯苯共聚物制备超高交联乙烯-二乙烯苯树脂,使超高交联乙烯-二乙烯苯树脂具有丰富的孔道结构,能够吸附尿毒症毒素中的中大分子物质和小分子蛋白结合毒素,并在低交联苯乙烯-二乙烯苯共聚物交联反应过程中加入聚乙烯亚胺,利用反应过程中产生的氯甲基使聚乙烯亚胺固载至超高交联苯乙烯-二乙烯苯树脂上,能够避免引入其它试剂或其它物质,不仅有利于简化反应流程,提高反应效率,还能够避免影响超高交联苯乙烯-二乙烯苯树脂的吸附性能;后续通过将超高交联苯乙烯-二乙烯苯树脂浸泡至吸附配基溶液中,能够使吸附配基进入至超高交联苯乙烯-二乙烯苯树脂的孔道结构中,有利于吸附配基与超高交联苯乙烯-二乙烯苯树脂上固载的聚乙烯亚胺充分接触并结合,有利于聚乙烯亚胺与吸附配基结合。本发明提供的制备方法,对反应步骤进行了简化,制备过程简单,反应条件温和,反应过程中的安全性较高,生产成本较低,有利于工业化大批量生产。The preparation method of the protein-bound toxin adsorbent of the present invention comprises the following steps: firstly preparing a low-crosslinked styrene-divinylbenzene copolymer by suspension polymerization, and then preparing an ultra-high crosslinked ethylene-divinylbenzene resin by the low-crosslinked styrene-divinylbenzene copolymer, so that the ultra-high crosslinked ethylene-divinylbenzene resin has a rich pore structure and can adsorb medium and macromolecular substances and small molecular protein-bound toxins in uremic toxins; and adding polyethyleneimine during the crosslinking reaction of the low-crosslinked styrene-divinylbenzene copolymer, and using the chloromethyl groups generated during the reaction to immobilize the polyethyleneimine on the ultra-high crosslinked styrene-divinylbenzene resin, so as to avoid introducing other reagents or other substances, which is not only conducive to simplifying the reaction process and improving the reaction efficiency, but also can avoid affecting the adsorption performance of the ultra-high crosslinked styrene-divinylbenzene resin; and subsequently, by soaking the ultra-high crosslinked styrene-divinylbenzene resin in an adsorption ligand solution, the adsorption ligand can enter the pore structure of the ultra-high crosslinked styrene-divinylbenzene resin, which is conducive to the adsorption ligand fully contacting and combining with the polyethyleneimine immobilized on the ultra-high crosslinked styrene-divinylbenzene resin, and is conducive to the combination of polyethyleneimine and the adsorption ligand. The preparation method provided by the present invention simplifies the reaction steps, has a simple preparation process, mild reaction conditions, high safety during the reaction process, low production cost, and is conducive to industrial mass production.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为本发明实施例提供的制备蛋白结合毒素吸附剂的工艺流程图。FIG1 is a process flow chart for preparing a protein-bound toxin adsorbent according to an embodiment of the present invention.
具体实施方式Detailed ways
为使本发明的上述目的、特征和优点能够更为明显易懂,下面结合附图对本发明的具体实施例做详细的说明。In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, specific embodiments of the present invention are described in detail below with reference to the accompanying drawings.
需要说明的是,在不冲突的情况下,本发明中的实施例及实施例中的特征可以相互组合。It should be noted that, in the absence of conflict, the embodiments of the present invention and the features in the embodiments may be combined with each other.
另外,术语“包含”、“包括”、“含有”、“具有”的含义是非限制性的,即可加入不影响结果的其它步骤和其它成分。如无特殊说明的,材料、设备、试剂均为市售。In addition, the terms "comprising", "including", "containing", and "having" are not restrictive, that is, other steps and other components that do not affect the results can be added. Unless otherwise specified, materials, equipment, and reagents are commercially available.
此外,本发明虽然对制备中的各步骤进行了如S110、S120、S130等形式的描述,但此描述方式仅为了便于理解,如S110、S120、S130等形式并不表示对各步骤先后顺序的限定。In addition, although the present invention describes the various steps in the preparation in the form of S110, S120, S130, etc., this description is only for ease of understanding, and the form of S110, S120, S130, etc. does not limit the sequence of the steps.
本申请的实施例第一方面提供了一种蛋白结合毒素吸附剂,该蛋白结合毒素吸附剂以超高交联苯乙烯-二乙烯苯树脂为载体,载体上固载有聚乙烯亚胺,聚乙烯亚胺连接有吸附配基,吸附配基包括α-甲基-4-(2-甲基丙基)苯乙酸、油酸和亚油酸中的至少一种。The first aspect of the embodiments of the present application provides a protein-bound toxin adsorbent, which uses an ultra-high cross-linked styrene-divinylbenzene resin as a carrier, on which polyethyleneimine is immobilized, and the polyethyleneimine is connected to an adsorption ligand, and the adsorption ligand includes at least one of α-methyl-4-(2-methylpropyl)phenylacetic acid, oleic acid and linoleic acid.
其中,蛋白结合毒素包括马尿酸(HA)、吲哚-3-乙酸(IAA)、硫酸吲哚酚(IS)、硫酸对甲酚(PCS)、3-羧基-4-甲基-5-丙基-2-呋喃丙酸(CMPF)。本实施例中的蛋白结合毒素吸附剂能够对上述几种蛋白结合毒素进行吸附,尤其是对IAA、IS和PCS能够进行特异性吸附。Among them, protein-bound toxins include hippuric acid (HA), indole-3-acetic acid (IAA), indoxyl sulfate (IS), p-cresol sulfate (PCS), and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF). The protein-bound toxin adsorbent in this embodiment can adsorb the above-mentioned protein-bound toxins, especially IAA, IS and PCS.
具体地,α-甲基-4-(2-甲基丙基)苯乙酸,也即布洛芬,其具有π电子共轭结构和羧基,其羧基在pH中性条件下解离,带一个单位负电荷,带负电荷的羧基可与带正电荷的基团发生静电相互作用,且其苯环与空腔中部环状分布的四个亮氨酸形成疏水相互作用;并且,α-甲基-4-(2-甲基丙基)苯乙酸具有与对甲酚硫酸盐和吲哚酚硫酸盐相同的白蛋白结合位点,在α-甲基-4-(2-甲基丙基)苯乙酸的疏水作用和静电相互作用的辅助下,α-甲基-4-(2-甲基丙基)苯乙酸能够与蛋白结合毒素竞争吸附于白蛋白,且α-甲基-4-(2-甲基丙基)苯乙酸与白蛋白的结合力强于蛋白结合毒素和白蛋白的结合力,从而使蛋白结合毒素从白蛋白上脱落,使蛋白结合毒素呈游离态,便于蛋白结合毒素吸附剂对蛋白结合毒素进行吸附。Specifically, α-methyl-4-(2-methylpropyl)phenylacetic acid, also known as ibuprofen, has a π-electron conjugated structure and a carboxyl group. The carboxyl group dissociates under neutral pH conditions and carries a unit negative charge. The negatively charged carboxyl group can electrostatically interact with the positively charged group, and its benzene ring forms a hydrophobic interaction with the four leucines distributed in a ring in the middle of the cavity; and α-methyl-4-(2-methylpropyl)phenylacetic acid has the same albumin binding site as p-cresol sulfate and indoxyl sulfate. With the assistance of the hydrophobic effect and electrostatic interaction of α-methyl-4-(2-methylpropyl)phenylacetic acid, α-methyl-4-(2-methylpropyl)phenylacetic acid can compete with protein-bound toxins for adsorption on albumin, and the binding force between α-methyl-4-(2-methylpropyl)phenylacetic acid and albumin is stronger than the binding force between protein-bound toxins and albumin, thereby causing the protein-bound toxins to fall off from the albumin, making the protein-bound toxins free, making it easier for the protein-bound toxin adsorbent to adsorb the protein-bound toxins.
油酸和亚油酸也都具有羧基,羧基在pH中性条件下解离,带一个单位负电荷,带负电荷的羧基可与带正电荷的基团发生静电相互作用,且这两个物质均具有疏水作用,以及具有与甲酚硫酸盐和吲哚酚硫酸盐相同的白蛋白结合位点,在蛋白结合毒素吸附剂上连接油酸和/或亚油酸,在油酸和/或亚油酸的疏水作用和静电相互作用的辅助下,能够使蛋白结合毒素从白蛋白上脱落,使蛋白结合毒素呈游离态,便于蛋白结合毒素吸附剂对蛋白结合毒素进行吸附。Oleic acid and linoleic acid also have carboxyl groups, which dissociate under neutral pH conditions and carry a unit of negative charge. The negatively charged carboxyl group can undergo electrostatic interactions with positively charged groups, and both substances have hydrophobic effects and the same albumin binding sites as cresol sulfate and indoxyl sulfate. Oleic acid and/or linoleic acid are connected to the protein-bound toxin adsorbent. With the assistance of the hydrophobic effect and electrostatic interaction of oleic acid and/or linoleic acid, the protein-bound toxins can fall off the albumin, making the protein-bound toxins free, making it easier for the protein-bound toxin adsorbent to adsorb the protein-bound toxins.
此外,α-甲基-4-(2-甲基丙基)苯乙酸用于人体安全性高,且可代谢,毒副作用较小;油酸具有顺反异构体,对软化血管有一定效用,在人和动物的新陈代谢过程中也起着重要作用;亚油酸是人体必须的脂肪酸,其能够降低血液胆固醇,预防动脉粥样硬化;由此,α-甲基-4-(2-甲基丙基)苯乙酸、油酸和亚油酸应用于蛋白结合毒素吸附剂的安全性较高。In addition, α-methyl-4-(2-methylpropyl)phenylacetic acid is highly safe for human use, can be metabolized, and has less toxic side effects; oleic acid has cis-trans isomers, has a certain effect on softening blood vessels, and also plays an important role in the metabolism of humans and animals; linoleic acid is an essential fatty acid for the human body, which can lower blood cholesterol and prevent atherosclerosis; therefore, α-methyl-4-(2-methylpropyl)phenylacetic acid, oleic acid and linoleic acid are relatively safe for use in protein-bound toxin adsorbents.
本实施例中,超高交联苯乙烯-二乙烯苯树脂由低交联苯乙烯-二乙烯苯共聚物进行交联反应制得,聚乙烯亚胺在低交联苯乙烯-二乙烯苯共聚物交联反应过程中引入,吸附配基通过静电吸附连接至聚乙烯亚胺。In this embodiment, ultra-high cross-linked styrene-divinylbenzene resin is prepared by cross-linking reaction of low-cross-linked styrene-divinylbenzene copolymer, polyethyleneimine is introduced during the cross-linking reaction of the low-cross-linked styrene-divinylbenzene copolymer, and the adsorption ligand is connected to the polyethyleneimine by electrostatic adsorption.
具体地,超高交联苯乙烯-二乙烯苯树脂由低交联苯乙烯-二乙烯苯共聚物进行氯甲基化反应和傅克反应交联制得,聚乙烯亚胺在低交联苯乙烯-二乙烯苯共聚物进行氯甲基化反应的过程中引入,聚乙烯亚胺解离带有正电荷,吸附配基带有负电荷,聚乙烯亚胺的正电荷和吸附配基的负电荷通过静电相互作用结合,使吸附配基连接至聚乙烯亚胺上。由此,通过低交联苯乙烯-二乙烯苯共聚物在反应过程中产生的氯甲基共价接枝聚乙烯亚胺,能够避免引入其它试剂或其它物质,并且聚乙烯亚胺通过共价键结合至超高交联苯乙烯-二乙烯苯树脂上,能够提高聚乙烯亚胺固载在超高交联苯乙烯-二乙烯苯树脂上的结合强度,避免聚乙烯亚胺脱落,影响超高交联苯乙烯-二乙烯苯树脂的吸附性能;此外,通过静电吸附将吸附配基连接至聚乙烯亚胺,便于在后续使用过程中,吸附配基从蛋白结合毒素吸附剂上脱落进入血液中,一方面使吸附配基与蛋白结合毒素进行竞争吸附,使蛋白结合毒素从白蛋白上脱落,增加蛋白结合毒素的游离,另一方面带有负电荷的吸附配基通过静电相互作用与聚乙烯亚胺连接,当吸附配基脱落进入血液中,吸附配基在静电相互作用下会与白蛋白结合,使血液中游离的吸附配基的数量减少,为了保持静电相互作用的稳定性,会促进吸附配基从蛋白结合毒素上脱落,以使静电相互作用和吸附配基的脱落达到一种平衡状态,从而有利于进一步增加蛋白结合毒素的游离,进一步提高蛋白结合毒素吸附剂对游离的蛋白结合毒素的吸附性。Specifically, the ultra-high cross-linked styrene-divinylbenzene resin is prepared by chloromethylation reaction and Friedel-Crafts cross-linking of low-cross-linked styrene-divinylbenzene copolymer, and polyethyleneimine is introduced in the process of chloromethylation reaction of low-cross-linked styrene-divinylbenzene copolymer, polyethyleneimine dissociates with positive charge, and adsorption ligand has negative charge, and the positive charge of polyethyleneimine and the negative charge of adsorption ligand are combined through electrostatic interaction, so that the adsorption ligand is connected to polyethyleneimine. Therefore, by covalently grafting polyethyleneimine with chloromethyl generated in the reaction process of low-cross-linked styrene-divinylbenzene copolymer, the introduction of other reagents or other substances can be avoided, and polyethyleneimine is covalently bonded to the ultra-high cross-linked styrene-divinylbenzene resin, which can improve the binding strength of polyethyleneimine immobilized on the ultra-high cross-linked styrene-divinylbenzene resin, avoid polyethyleneimine falling off, and affect the adsorption performance of ultra-high cross-linked styrene-divinylbenzene resin; in addition, the adsorption ligand is connected to polyethyleneimine by electrostatic adsorption, which is convenient for the adsorption ligand to fall off from the protein-bound toxin adsorbent and enter the blood during subsequent use, so that the adsorption ligand is bound to the protein. The toxins are competitively adsorbed, causing the protein-bound toxins to fall off from albumin, increasing the release of protein-bound toxins. On the other hand, the negatively charged adsorption ligands are connected to polyethyleneimine through electrostatic interactions. When the adsorption ligands fall off and enter the blood, they will bind to albumin under electrostatic interactions, reducing the number of free adsorption ligands in the blood. In order to maintain the stability of the electrostatic interaction, the adsorption ligands will be promoted to fall off from the protein-bound toxins, so that the electrostatic interaction and the shedding of the adsorption ligands reach a state of equilibrium, which is beneficial to further increase the release of protein-bound toxins and further improve the adsorption of free protein-bound toxins by the protein-bound toxin adsorbent.
本实施例中,聚乙烯亚胺的固载量范围为0.1mmol/g至1mmol/g,即每1g蛋白结合毒素吸附剂上聚乙烯亚胺的固载量为0.1mmol至1mmol。由此,能够静电吸附适宜量的吸附配基,进一步提高蛋白结合毒素吸附剂对蛋白结合毒素的清除率,同时,能够避免吸附配基的量过多,短时间内释放至血液中,引起机体的不适,降低了蛋白结合毒素吸附剂的使用安全性。In this embodiment, the immobilized amount of polyethyleneimine ranges from 0.1mmol/g to 1mmol/g, that is, the immobilized amount of polyethyleneimine per 1g of protein-bound toxin adsorbent is from 0.1mmol to 1mmol. Thus, an appropriate amount of adsorbent ligand can be electrostatically adsorbed, further improving the clearance rate of protein-bound toxins by the protein-bound toxin adsorbent, and at the same time, it can avoid excessive amount of adsorbent ligand being released into the blood in a short period of time, causing discomfort to the body, and reducing the safety of the protein-bound toxin adsorbent.
需要说明的是,本实施例中对超高交联苯乙烯-二乙烯苯树脂的交联度和低交联苯乙烯-二乙烯苯共聚物的交联度的具体数值范围不做进一步地限定,本领域的技术人员可以根据实际情况进行调整,只要能够保证超高交联苯乙烯-二乙烯苯树脂的交联度高于低交联苯乙烯-二乙烯苯共聚物的交联度即可。It should be noted that, in this embodiment, the specific numerical ranges of the crosslinking degree of the ultra-high crosslinked styrene-divinylbenzene resin and the crosslinking degree of the low crosslinked styrene-divinylbenzene copolymer are not further limited, and those skilled in the art can make adjustments according to actual conditions, as long as the crosslinking degree of the ultra-high crosslinked styrene-divinylbenzene resin can be ensured to be higher than the crosslinking degree of the low crosslinked styrene-divinylbenzene copolymer.
多数蛋白结合毒素含有芳香环和/或吲哚环,同时具有离子功能团,使蛋白结合毒素容易与血清白蛋白结合,形成体积较大的蛋白结合形态,造成蛋白结合毒素的游离分数较小,而蛋白结合毒素在体内的分布容积远远大于血浆容积,使得蛋白结合毒素难以清除。本申请的发明人,基于蛋白结合毒素的上述特性进行了分析,提供了一种蛋白结合毒素吸附剂,该蛋白结合毒素吸附剂以超高交联苯乙烯-二乙烯苯树脂为载体,固载聚乙烯亚胺,聚乙烯亚胺连接有吸附配基,吸附配基带有负电荷,将该蛋白结合毒素吸附剂与血液接触,吸附配基从蛋白结合毒素吸附剂上脱落进入血液中,吸附配基具有与对甲酚硫酸盐和吲哚酚硫酸盐相同的白蛋白结合位点,其能够与蛋白结合毒素竞争吸附于白蛋白,且吸附配基与白蛋白的结合力强于蛋白结合毒素和白蛋白的结合力,使蛋白结合毒素从白蛋白上脱落,使蛋白结合毒素呈游离态,便于超高交联苯乙烯-二乙烯苯树脂和其上固载的聚乙烯亚胺对蛋白结合毒素进行吸附,提高对蛋白结合毒素的清除率;同时,以超高交联苯乙烯-二乙烯苯树脂为载体,超高交联苯乙烯-二乙烯苯树脂具有丰富的孔道结构,能够吸附尿毒症毒素中的中大分子物质和小分子蛋白结合毒素,超高交联苯乙烯-二乙烯苯树脂上固载的聚乙烯亚胺,带有正电荷,其能够与血液中的游离的蛋白结合毒素进行静电结合,对蛋白结合毒素进行清除。本实施例中,通过吸附配基的作用使蛋白结合毒素呈游离态,同时通过超高交联苯乙烯-二乙烯苯树脂的吸附作用和聚乙烯亚胺的静电结合作用,对游离态的蛋白结合毒素进行清除,提高了对蛋白结合毒素的清除率。Most protein-bound toxins contain aromatic rings and/or indole rings, and also have ionic functional groups, which make it easy for protein-bound toxins to bind to serum albumin, forming a larger protein-bound form, resulting in a smaller free fraction of protein-bound toxins. The distribution volume of protein-bound toxins in the body is much larger than the plasma volume, making protein-bound toxins difficult to remove. The inventors of the present application have conducted an analysis based on the above-mentioned characteristics of protein-bound toxins and provided a protein-bound toxin adsorbent. The protein-bound toxin adsorbent uses ultra-high cross-linked styrene-divinylbenzene resin as a carrier, immobilized polyethyleneimine, polyethyleneimine is connected to an adsorption ligand, and the adsorption ligand has a negative charge. When the protein-bound toxin adsorbent is contacted with blood, the adsorption ligand falls off the protein-bound toxin adsorbent and enters the blood. The adsorption ligand has the same albumin binding site as p-cresol sulfate and indoxyl sulfate, and can compete with protein-bound toxins for adsorption on albumin, and the binding force of the adsorption ligand to albumin is stronger than the binding force between the protein-bound toxin and albumin. , so that the protein-bound toxins fall off from the albumin, so that the protein-bound toxins are in a free state, which is convenient for the ultra-high cross-linked styrene-divinylbenzene resin and the polyethyleneimine immobilized thereon to adsorb the protein-bound toxins, thereby improving the clearance rate of the protein-bound toxins; at the same time, with the ultra-high cross-linked styrene-divinylbenzene resin as the carrier, the ultra-high cross-linked styrene-divinylbenzene resin has a rich pore structure, which can adsorb the medium and large molecular substances and small molecular protein-bound toxins in the uremic toxins, and the polyethyleneimine immobilized on the ultra-high cross-linked styrene-divinylbenzene resin has a positive charge, which can be electrostatically bound to the free protein-bound toxins in the blood, and the protein-bound toxins are removed. In this embodiment, the protein-bound toxins are freed by the action of the adsorption ligand, and the free protein-bound toxins are removed by the adsorption of the ultra-high cross-linked styrene-divinylbenzene resin and the electrostatic binding of the polyethyleneimine, thereby improving the clearance rate of the protein-bound toxins.
图1为本申请的实施例中提供的制备蛋白结合毒素吸附剂的工艺流程图。结合图1所示,本申请的实施例第二方面提供了一种用于制备第一方面所述的蛋白结合毒素吸附剂的制备方法,包括如下步骤:FIG1 is a process flow chart for preparing a protein-bound toxin adsorbent provided in an embodiment of the present application. In conjunction with FIG1 , a second aspect of an embodiment of the present application provides a method for preparing the protein-bound toxin adsorbent described in the first aspect, comprising the following steps:
步骤S110、制备低交联苯乙烯-二乙烯苯共聚物。Step S110, preparing a low-crosslinked styrene-divinylbenzene copolymer.
具体地,将苯乙烯类单体、多乙烯基交联剂、致孔剂和引发剂于分散介质进行悬浮聚合,制得低交联苯乙烯-二乙烯苯共聚物。Specifically, styrene monomers, polyvinyl crosslinking agents, porogens and initiators are suspended and polymerized in a dispersion medium to obtain a low-crosslinked styrene-divinylbenzene copolymer.
更具体地,将苯乙烯类单体、多乙烯基交联剂、致孔剂和引发剂混合形成油相,将分散介质、氯化钠和氯化镁混合形成水相,将油相加入水相中,在搅拌下于50℃至100℃进行悬浮聚合反应,反应10h至20h后,将悬浮聚合产物用水和乙醇清洗干净,干燥后,制得低交联苯乙烯-二乙烯苯共聚物。在进行悬浮聚合反应时,可以分阶段逐渐升温进行反应,例如:可以待油相在水相中形成一定大小的均匀液滴后,升温至75℃聚合反应5h,再升温至80℃反应5h,再升温至95℃至98℃,继续反应6h至8h后停止反应。More specifically, styrene monomers, polyvinyl crosslinking agents, porogens and initiators are mixed to form an oil phase, a dispersion medium, sodium chloride and magnesium chloride are mixed to form an aqueous phase, the oil phase is added to the aqueous phase, and suspension polymerization is carried out at 50°C to 100°C under stirring. After the reaction is carried out for 10 to 20 hours, the suspension polymerization product is cleaned with water and ethanol, and dried to obtain a low-crosslinked styrene-divinylbenzene copolymer. When carrying out the suspension polymerization reaction, the temperature can be gradually increased in stages for reaction. For example, after the oil phase forms uniform droplets of a certain size in the aqueous phase, the temperature can be increased to 75°C for polymerization reaction for 5 hours, then increased to 80°C for reaction for 5 hours, then increased to 95°C to 98°C, and the reaction is continued for 6 to 8 hours before stopping the reaction.
其中,苯乙烯类单体选自苯乙烯、甲基苯乙烯、乙基苯乙烯中的至少一种,较佳地,苯乙烯类单体为苯乙烯;多乙烯基交联剂选自二乙烯苯、二乙烯基甲苯、二乙烯基二甲苯、二乙烯基乙基苯中的至少一种,较佳地,多乙烯基交联剂为二乙烯苯。苯乙烯类单体占苯乙烯类单体和多乙烯基类交联剂总质量的20%至90%,多乙烯基交联剂占苯乙烯类单体和多乙烯基类交联剂总质量的10%至80%。由此,采用单乙烯基的苯乙烯类单体和多乙烯基的交联剂作为反应单体,使得苯乙烯-二乙烯苯共聚物部分交联,有利于提高低交联苯乙烯-二乙烯苯共聚物的力学强度以及在有机溶剂中的结构稳定性。Wherein, the styrene monomer is selected from at least one of styrene, methyl styrene, and ethyl styrene, preferably, the styrene monomer is styrene; the polyvinyl crosslinking agent is selected from at least one of divinylbenzene, divinyltoluene, divinylxylene, and divinylethylbenzene, preferably, the polyvinyl crosslinking agent is divinylbenzene. The styrene monomer accounts for 20% to 90% of the total mass of the styrene monomer and the polyvinyl crosslinking agent, and the polyvinyl crosslinking agent accounts for 10% to 80% of the total mass of the styrene monomer and the polyvinyl crosslinking agent. Therefore, by using monovinyl styrene monomers and polyvinyl crosslinking agents as reaction monomers, the styrene-divinylbenzene copolymer is partially crosslinked, which is beneficial to improve the mechanical strength of the low-crosslinked styrene-divinylbenzene copolymer and the structural stability in organic solvents.
致孔剂是芳烃类、烷烃类、高级醇类、高级酮类、酯类中的至少两种物质的混合物;其中,芳烃类选自甲苯、二甲苯;烷烃类选自正庚烷、200#汽油、固体石蜡;高级醇类选自丁醇、己醇、环己醇、异辛醇、正辛醇、甲基异丁基甲醇;高级酮类选自甲基异丁基甲酮、2-己酮、二异丁基甲酮、甲基特丁基酮;酯类选自乙酸丁酯、乙酸乙酯、丁酸丁酯;较佳地,致孔剂为甲苯和甲基异丁基甲醇。作为一种可选实施方式,致孔剂的质量可以为苯乙烯类单体和多乙烯基类交联剂总质量的70%至230%。The porogen is a mixture of at least two substances selected from aromatic hydrocarbons, alkanes, higher alcohols, higher ketones, and esters; wherein the aromatic hydrocarbons are selected from toluene and xylene; the alkanes are selected from n-heptane, 200# gasoline, and solid paraffin; the higher alcohols are selected from butanol, hexanol, cyclohexanol, isooctyl alcohol, n-octanol, and methyl isobutyl carbinol; the higher ketones are selected from methyl isobutyl ketone, 2-hexanone, diisobutyl ketone, and methyl tert-butyl ketone; the esters are selected from butyl acetate, ethyl acetate, and butyl butyrate; preferably, the porogen is toluene and methyl isobutyl carbinol. As an optional embodiment, the mass of the porogen can be 70% to 230% of the total mass of the styrene monomer and the polyvinyl crosslinking agent.
引发剂选自过氧化苯甲酰、过氧化-2-乙基己酸叔丁酯、过氧化-2-乙基己酸叔戊酯中的至少一种,较佳地,引发剂为过氧化苯甲酰。作为一种可选实施方式,引发剂的质量为苯乙烯类单体和多乙烯基类交联剂总质量的0.5%至1.5%。由此,采用上述引发剂能够有效引发聚合,且引发剂的价格较低。The initiator is selected from at least one of benzoyl peroxide, tert-butyl peroxy-2-ethylhexanoate, and tert-amyl peroxy-2-ethylhexanoate. Preferably, the initiator is benzoyl peroxide. As an optional embodiment, the mass of the initiator is 0.5% to 1.5% of the total mass of the styrene monomer and the polyvinyl crosslinking agent. Therefore, the use of the above initiator can effectively initiate polymerization, and the price of the initiator is relatively low.
分散介质为水,分散介质中具有分散剂,分散剂选自明胶、聚乙烯醇、羧甲基纤维素中的至少一种,较佳地,分散介质为明胶。作为一种可选实施方式,分散剂的质量为分散介质质量的0.5%至2%。由此,采用上述分散介质安全环保,并能够实现低交联苯乙烯-二乙烯苯共聚物的悬浮聚合。The dispersion medium is water, and the dispersion medium contains a dispersant, which is selected from at least one of gelatin, polyvinyl alcohol, and carboxymethyl cellulose. Preferably, the dispersion medium is gelatin. As an optional embodiment, the mass of the dispersant is 0.5% to 2% of the mass of the dispersion medium. Therefore, the use of the above dispersion medium is safe and environmentally friendly, and can achieve suspension polymerization of low-crosslinked styrene-divinylbenzene copolymer.
作为一种可选实施方式,氯化钠的质量为水相质量的3%至5%,氯化镁的质量为水相质量的2%至4%。其中,水相的质量为分散介质、分散剂、氯化钠和氯化镁的质量之和。As an optional embodiment, the mass of sodium chloride is 3% to 5% of the mass of the water phase, and the mass of magnesium chloride is 2% to 4% of the mass of the water phase. The mass of the water phase is the sum of the masses of the dispersion medium, the dispersant, the sodium chloride and the magnesium chloride.
步骤S120、低交联苯乙烯-二乙烯苯共聚物进行交联反应,制备超高交联苯乙烯-二乙烯苯树脂,其中,超高交联苯乙烯-二乙烯苯树脂上固载有聚乙烯亚胺,聚乙烯亚胺在低交联苯乙烯-二乙烯苯共聚物交联反应过程中固载至超高交联苯乙烯-二乙烯苯树脂上。Step S120, cross-linking the low-crosslinked styrene-divinylbenzene copolymer to prepare an ultra-high cross-linked styrene-divinylbenzene resin, wherein polyethyleneimine is immobilized on the ultra-high cross-linked styrene-divinylbenzene resin, and the polyethyleneimine is immobilized on the ultra-high cross-linked styrene-divinylbenzene resin during the cross-linking reaction of the low-crosslinked styrene-divinylbenzene copolymer.
具体地,将低交联苯乙烯-二乙烯苯共聚物进行氯甲基化反应,在氯甲基化反应过程中加入聚乙烯亚胺,制得含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物;将含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物进行傅克反应,制得超高交联苯乙烯-二乙烯苯树脂。Specifically, a low-crosslinked styrene-divinylbenzene copolymer is subjected to a chloromethylation reaction, and polyethyleneimine is added during the chloromethylation reaction to obtain a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine; and a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine is subjected to a Friedel-Crafts reaction to obtain an ultra-high crosslinked styrene-divinylbenzene resin.
更具体地,制备含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物,包括如下步骤:More specifically, the preparation of a low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine comprises the following steps:
将低交联苯乙烯-二乙烯苯共聚物加入二氯乙烷中于常温下进行溶胀,使低交联苯乙烯-二乙烯苯共聚物充分溶胀,将溶胀后的低交联苯乙烯-二乙烯苯共聚物、氯甲醚和无水三氯化铁在50℃至60℃下回流反应2h至4h后,升温至80℃至100℃继续回流反应5h至24h,同时,在升温的过程中加入聚乙烯亚胺进行反应,将聚乙烯亚胺引入至低交联苯乙烯-二乙烯苯共聚物上,制得含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物。由此,在50℃至60℃下,低交联苯乙烯-二乙烯苯共聚物和氯甲醚进行氯甲基化反应后,在低交联苯乙烯-二乙烯苯共聚物上引入氯甲基,再升温至80℃至100℃,并在升温的过程中加入聚乙烯亚胺,使氯甲基与聚乙烯亚胺的胺基进行改性反应,从而将聚乙烯亚胺引入至低交联苯乙烯-二乙烯苯共聚物上,同时在后续的升温过程中继续进行氯甲基化反应,在低交联苯乙烯-二乙烯苯共聚物上引入足量氯甲基,使氯甲基过量于聚乙烯亚胺;本实施例中通过在低交联苯乙烯-二乙烯苯共聚物反应过程中产生的氯甲基共价接枝聚乙烯亚胺,一方面能够避免引入其它试剂或其它物质,且聚乙烯亚胺通过共价键结合至超高交联苯乙烯-二乙烯苯树脂上,能够提高聚乙烯亚胺固载在超高交联苯乙烯-二乙烯苯树脂上的结合强度,避免聚乙烯亚胺脱落,影响后续制得的超高交联苯乙烯-二乙烯苯树脂的吸附性能,另一方面能够确保引入足量的氯甲基,便于后续进行傅克反应,提高载体的强度和结构稳定性。A low-crosslinked styrene-divinylbenzene copolymer is added to ethylene dichloride and swelled at room temperature to fully swell the low-crosslinked styrene-divinylbenzene copolymer. The swollen low-crosslinked styrene-divinylbenzene copolymer, chloromethyl ether and anhydrous ferric chloride are refluxed at 50° C. to 60° C. for 2 h to 4 h, and then the temperature is raised to 80° C. to 100° C. for further reflux reaction for 5 h to 24 h. Meanwhile, polyethyleneimine is added during the heating process for reaction, and the polyethyleneimine is introduced into the low-crosslinked styrene-divinylbenzene copolymer to obtain a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine. Thus, after the low-crosslinked styrene-divinylbenzene copolymer and chloromethyl ether undergo chloromethylation reaction at 50° C. to 60° C., chloromethyl groups are introduced into the low-crosslinked styrene-divinylbenzene copolymer, and then the temperature is raised to 80° C. to 100° C., and polyethyleneimine is added during the heating process to modify the chloromethyl groups with the amine groups of the polyethyleneimine, thereby introducing the polyethyleneimine into the low-crosslinked styrene-divinylbenzene copolymer, and the chloromethylation reaction is continued during the subsequent heating process to introduce sufficient chloromethyl groups into the low-crosslinked styrene-divinylbenzene copolymer so that the chloromethyl groups are in excess of the polyethyleneimine; this embodiment In the example, the chloromethyl groups produced in the reaction process of the low-crosslinked styrene-divinylbenzene copolymer are covalently grafted onto polyethyleneimine, which can avoid the introduction of other reagents or other substances, and the polyethyleneimine is covalently bonded to the ultra-high crosslinked styrene-divinylbenzene resin, which can improve the binding strength of the polyethyleneimine immobilized on the ultra-high crosslinked styrene-divinylbenzene resin and avoid the polyethyleneimine from falling off and affecting the adsorption performance of the subsequently prepared ultra-high crosslinked styrene-divinylbenzene resin. On the other hand, it can ensure the introduction of sufficient chloromethyl groups to facilitate the subsequent Friedel-Crafts reaction and improve the strength and structural stability of the carrier.
其中,低交联苯乙烯-二乙烯苯共聚物和氯甲醚的质量比为1:4至1:6,低交联苯乙烯-二乙烯苯共聚物和无水三氯化铁的质量比为1:0.5至1:1.5;低交联苯乙烯-二乙烯苯共聚物和聚乙烯亚胺的质量比为20:5至20:20,聚乙烯亚胺的分子量为200至10000。由此,将各个物质的用量比限制在上述范围内,能够保证在低交联苯乙烯-二乙烯苯共聚物上引入足量的氯甲基,使部分氯甲基能够与聚乙烯亚胺反应,剩余部分的氯甲基能够进行后续的傅克反应,形成超高交联苯乙烯-二乙烯苯树脂。本实施例中含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物中氯含量范围为1%至5%。Among them, the mass ratio of low cross-linked styrene-divinylbenzene copolymer and chloromethyl ether is 1:4 to 1:6, the mass ratio of low cross-linked styrene-divinylbenzene copolymer and anhydrous ferric chloride is 1:0.5 to 1:1.5; the mass ratio of low cross-linked styrene-divinylbenzene copolymer and polyethyleneimine is 20:5 to 20:20, and the molecular weight of polyethyleneimine is 200 to 10000. Therefore, by limiting the usage ratio of each substance within the above range, it is possible to ensure that a sufficient amount of chloromethyl is introduced into the low cross-linked styrene-divinylbenzene copolymer, so that part of the chloromethyl can react with polyethyleneimine, and the remaining part of the chloromethyl can undergo subsequent Friedel-Crafts reaction to form ultra-high cross-linked styrene-divinylbenzene resin. The chlorine content in the low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine in this embodiment ranges from 1% to 5%.
制得含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物后,将含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物清洗干净后,将含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物和硝基苯混合后,于35℃至45℃下静置溶胀4h至5h,再在搅拌下加入氯化锌,使氯甲基进行傅克反应,形成超高交联苯乙烯-二乙烯苯树脂,其中,傅克反应的温度为110℃至130℃,反应时间为8h至16h。由此,使含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物上残留的氯甲基进行傅克反应,一方面能够提高制得的超高交联苯乙烯-二乙烯苯树脂的强度和结构稳定性,另一方面有利于形成更多的微孔孔道结构,提高超高交联苯乙烯-二乙烯苯树脂对小分子蛋白结合类毒素的吸附性。本实施例中得到的超高交联苯乙烯-二乙烯苯树脂上固载有聚乙烯亚胺,聚乙烯亚胺的固载量范围为0.1mmol/g至1mmol/g,即每1g蛋白结合毒素吸附剂上聚乙烯亚胺的固载量为0.1mmol至1mmol。After obtaining a low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine, the low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine is cleaned, and then the low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine is mixed with nitrobenzene, and then allowed to swell at 35°C to 45°C for 4h to 5h, and then zinc chloride is added under stirring to make the chloromethyl group undergo a Friedel-Crafts reaction to form an ultra-high cross-linked styrene-divinylbenzene resin, wherein the Friedel-Crafts reaction temperature is 110°C to 130°C, and the reaction time is 8h to 16h. Thus, the residual chloromethyl group on the low cross-linked styrene-divinylbenzene copolymer containing polyethyleneimine undergoes a Friedel-Crafts reaction, which can improve the strength and structural stability of the ultra-high cross-linked styrene-divinylbenzene resin on the one hand, and is conducive to forming more microporous channel structures, and improving the adsorption of the ultra-high cross-linked styrene-divinylbenzene resin to small molecule protein-bound toxins. The ultra-high cross-linked styrene-divinylbenzene resin obtained in this embodiment is immobilized with polyethyleneimine, and the immobilized amount of polyethyleneimine ranges from 0.1mmol/g to 1mmol/g, that is, the immobilized amount of polyethyleneimine per 1g of protein-bound toxin adsorbent is 0.1mmol to 1mmol.
其中,硝基苯的质量为含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物质量的5倍至7倍;氯化锌的质量为含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物质量的0.1倍至0.5倍。The mass of nitrobenzene is 5 to 7 times of the mass of the low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine; the mass of zinc chloride is 0.1 to 0.5 times of the mass of the low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine.
在制得超高交联苯乙烯-二乙烯苯树脂之后,还包括:将超高交联苯乙烯-二乙烯苯树脂先用乙醇清洗至澄清后,再用质量分数为5%的稀盐酸清洗,然后用乙醇索氏抽提,烘干后,得到净化的超高交联苯乙烯-二乙烯苯树脂。After the ultra-high cross-linked styrene-divinylbenzene resin is prepared, the method further includes: washing the ultra-high cross-linked styrene-divinylbenzene resin with ethanol until it is clarified, then washing it with dilute hydrochloric acid with a mass fraction of 5%, then extracting it with ethanol Soxhlet, and drying it to obtain purified ultra-high cross-linked styrene-divinylbenzene resin.
步骤S130、将超高交联苯乙烯-二乙烯苯树脂浸泡至吸附配基溶液中,浸泡结束后,吸附配基连接至聚乙烯亚胺上,制得蛋白结合毒素吸附剂。Step S130, soaking the ultra-high cross-linked styrene-divinylbenzene resin in the adsorption ligand solution. After the soaking, the adsorption ligand is connected to the polyethyleneimine to obtain a protein-bound toxin adsorbent.
具体地,将超高交联苯乙烯-二乙烯苯树脂浸泡至碱性溶液中,直至碱性溶液的pH值不变,得到转型后的超高交联苯乙烯-二乙烯苯树脂,将转型后的超高交联苯乙烯-二乙烯苯树脂清洗和干燥后,浸泡至吸附配基溶液中,浸泡结束后,清洗干净,制得蛋白结合毒素吸附剂,其中,吸附配基溶液中吸附配基的质量百分比为10%至40%,超高交联苯乙烯-二乙烯苯树脂和吸附配基溶液的体积比为1:1.2至1:1.5。由此,通过将超高交联苯乙烯-二乙烯苯树脂浸泡至碱性溶液中,使超高交联苯乙烯-二乙烯苯树脂上的氯离子转型成氢氧根离子,有利于超高交联苯乙烯-二乙烯苯树脂上的聚乙烯亚胺解离,使聚乙烯亚胺带正电荷,便于在超高交联苯乙烯-二乙烯苯树脂浸泡至吸附配基溶液中时,使带正电荷的聚乙烯亚胺吸引更多的带负电荷的吸附配基,并使聚乙烯亚胺的正电荷通过静电相互作用与带负电荷的吸附配基相结合,从而使更多吸附配基连接至聚乙烯亚胺上;此外,将超高交联苯乙烯-二乙烯苯树脂浸泡至吸附配基溶液中,能够使吸附配基进入至超高交联苯乙烯-二乙烯苯树脂的孔道结构中,有利于吸附配基与超高交联苯乙烯-二乙烯苯树脂上固载的聚乙烯亚胺充分接触并结合,有利于提高超高交联苯乙烯-二乙烯苯树脂上吸附配基的量。Specifically, an ultra-high cross-linked styrene-divinylbenzene resin is immersed in an alkaline solution until the pH value of the alkaline solution remains unchanged to obtain a transformed ultra-high cross-linked styrene-divinylbenzene resin. The transformed ultra-high cross-linked styrene-divinylbenzene resin is washed and dried, and then immersed in an adsorption ligand solution. After the soaking, the resin is washed to obtain a protein-bound toxin adsorbent, wherein the mass percentage of the adsorption ligand in the adsorption ligand solution is 10% to 40%, and the volume ratio of the ultra-high cross-linked styrene-divinylbenzene resin to the adsorption ligand solution is 1:1.2 to 1:1.5. Thus, by immersing the ultra-high cross-linked styrene-divinylbenzene resin in an alkaline solution, the chloride ions on the ultra-high cross-linked styrene-divinylbenzene resin are transformed into hydroxide ions, which is beneficial to the dissociation of the polyethyleneimine on the ultra-high cross-linked styrene-divinylbenzene resin, so that the polyethyleneimine is positively charged, so that when the ultra-high cross-linked styrene-divinylbenzene resin is immersed in the adsorption ligand solution, the positively charged polyethyleneimine attracts more negatively charged adsorption ligands, and the positive charge of the polyethyleneimine is combined with the negatively charged adsorption ligand through electrostatic interaction, so that more adsorption ligands are connected to the polyethyleneimine; in addition, immersing the ultra-high cross-linked styrene-divinylbenzene resin in the adsorption ligand solution can make the adsorption ligand enter the pore structure of the ultra-high cross-linked styrene-divinylbenzene resin, which is beneficial for the adsorption ligand to fully contact and combine with the polyethyleneimine immobilized on the ultra-high cross-linked styrene-divinylbenzene resin, and is beneficial to increase the amount of adsorption ligands on the ultra-high cross-linked styrene-divinylbenzene resin.
其中,碱性溶液为NaOH溶液,NaOH溶液的浓度为0.1mol/L。转型后的超高交联苯乙烯-二乙烯苯树脂在吸附配基溶液中浸泡24h至30h,以使吸附配基与超高交联苯乙烯-二乙烯苯树脂上固载的聚乙烯亚胺充分接触。较佳地,在将转型后的超高交联苯乙烯-二乙烯苯树脂,浸泡至吸附配基溶液时,可以搅拌吸附配基溶液,通过边搅拌边浸泡的方式,有利于吸附配基和超高交联苯乙烯-二乙烯苯树脂上聚乙烯亚胺的结合。The alkaline solution is a NaOH solution, and the concentration of the NaOH solution is 0.1 mol/L. The transformed ultra-high cross-linked styrene-divinylbenzene resin is soaked in the adsorption ligand solution for 24 to 30 hours to allow the adsorption ligand to fully contact the polyethyleneimine immobilized on the ultra-high cross-linked styrene-divinylbenzene resin. Preferably, when the transformed ultra-high cross-linked styrene-divinylbenzene resin is soaked in the adsorption ligand solution, the adsorption ligand solution can be stirred, and the method of stirring and soaking is conducive to the combination of the adsorption ligand and the polyethyleneimine on the ultra-high cross-linked styrene-divinylbenzene resin.
本实施例中,用去离子水将转型后的超高交联苯乙烯-二乙烯苯树脂清洗干净,能够避免影响超高交联苯乙烯-二乙烯苯树脂上基团的活性,并避免酸碱性的变化,影响超高交联苯乙烯-二乙烯苯树脂上的聚乙烯亚胺解离。In this embodiment, the transformed ultra-high cross-linked styrene-divinylbenzene resin is cleaned with deionized water to avoid affecting the activity of the groups on the ultra-high cross-linked styrene-divinylbenzene resin and avoid changes in acidity and alkalinity that affect the dissociation of polyethyleneimine on the ultra-high cross-linked styrene-divinylbenzene resin.
超高交联苯乙烯-二乙烯苯树脂在吸附配基溶液中浸泡结束后,用去离子水清洗,得到蛋白结合毒素吸附剂,采用去离子水清洗能够避免影响吸附配基和聚乙烯亚胺的结合,避免使吸附配基从聚乙烯亚胺上脱落,从而有利于确保蛋白结合毒素吸附剂的结构稳定性。After the ultra-high cross-linked styrene-divinylbenzene resin is soaked in the adsorption ligand solution, it is washed with deionized water to obtain a protein-bound toxin adsorbent. The use of deionized water for washing can avoid affecting the binding of the adsorption ligand and polyethyleneimine, and avoid the adsorption ligand falling off from the polyethyleneimine, which is beneficial to ensure the structural stability of the protein-bound toxin adsorbent.
本实施例中提供的蛋白结合毒素吸附剂的制备方法,先通过悬浮聚合反应制备低交联苯乙烯-二乙烯苯共聚物,再通过低交联苯乙烯-二乙烯苯共聚物制备超高交联乙烯-二乙烯苯树脂,使超高交联乙烯-二乙烯苯树脂具有丰富的孔道结构,能够吸附尿毒症毒素中的中大分子物质和小分子蛋白结合毒素,并在低交联苯乙烯-二乙烯苯共聚物交联反应过程中加入聚乙烯亚胺,利用反应过程中产生的氯甲基使聚乙烯亚胺固载至超高交联苯乙烯-二乙烯苯树脂上,能够避免引入其它试剂或其它物质,不仅有利于简化反应流程,提高反应效率,还能够避免影响超高交联苯乙烯-二乙烯苯树脂的吸附性能;后续通过将超高交联苯乙烯-二乙烯苯树脂浸泡至吸附配基溶液中,能够使吸附配基进入至超高交联苯乙烯-二乙烯苯树脂的孔道结构中,有利于吸附配基与超高交联苯乙烯-二乙烯苯树脂上固载的聚乙烯亚胺充分接触并结合,有利于聚乙烯亚胺与吸附配基结合。本实施例中提供的制备方法,对反应步骤进行了简化,制备过程简单,反应条件温和,反应过程中的安全性较高,生产成本较低,有利于工业化大批量生产。The preparation method of the protein-bound toxin adsorbent provided in this embodiment is to first prepare a low-crosslinked styrene-divinylbenzene copolymer by suspension polymerization, and then prepare an ultra-high cross-linked ethylene-divinylbenzene resin by the low-crosslinked styrene-divinylbenzene copolymer, so that the ultra-high cross-linked ethylene-divinylbenzene resin has a rich pore structure and can adsorb medium and large molecular substances and small molecular protein-bound toxins in uremic toxins, and add polyethyleneimine during the cross-linking reaction of the low-crosslinked styrene-divinylbenzene copolymer, and use the chloromethyl groups generated during the reaction to immobilize the polyethyleneimine on the ultra-high cross-linked styrene-divinylbenzene resin, which can avoid the introduction of other reagents or other substances, which is not only conducive to simplifying the reaction process and improving the reaction efficiency, but also can avoid affecting the adsorption performance of the ultra-high cross-linked styrene-divinylbenzene resin; subsequently, by immersing the ultra-high cross-linked styrene-divinylbenzene resin in an adsorption ligand solution, the adsorption ligand can enter the pore structure of the ultra-high cross-linked styrene-divinylbenzene resin, which is conducive to the adsorption ligand and the polyethyleneimine immobilized on the ultra-high cross-linked styrene-divinylbenzene resin Full contact and combination, which is conducive to the combination of polyethyleneimine and the adsorption ligand. The preparation method provided in this embodiment simplifies the reaction steps, has a simple preparation process, mild reaction conditions, high safety during the reaction process, low production cost, and is conducive to industrial mass production.
本申请的第三方面提供一种血液灌流器,该血液灌流器包括如上所述的蛋白结合毒素吸附剂,或者包括如上所述的蛋白结合毒素吸附剂的制备方法所制备的蛋白结合毒素吸附剂。将本申请提供的蛋白结合毒素吸附剂用于血液灌流器的吸附材料,在血液灌流时能够有效得去除尿毒症患者血液中的蛋白结合毒素,且该蛋白结合毒素吸附剂用于体外,不会进入体内,对人体的危害作用低。The third aspect of the present application provides a blood perfusion device, which includes the protein-bound toxin adsorbent as described above, or includes the protein-bound toxin adsorbent prepared by the preparation method of the protein-bound toxin adsorbent as described above. The protein-bound toxin adsorbent provided by the present application is used as the adsorption material of the blood perfusion device, which can effectively remove the protein-bound toxins in the blood of uremic patients during blood perfusion, and the protein-bound toxin adsorbent is used in vitro and will not enter the body, so it has low harmful effects on the human body.
为了对本发明进行进一步详细说明,下面将结合具体实施例对本发明进行进一步说明。本发明中的实施例中所使用的实验方法如无特殊说明,均为常规方法;本发明中的实施例中所用的材料、试剂等,如无特殊说明,均为市场购买所得。In order to further explain the present invention in detail, the present invention will be further explained in conjunction with specific examples. The experimental methods used in the examples of the present invention are all conventional methods unless otherwise specified; the materials, reagents, etc. used in the examples of the present invention are all purchased from the market unless otherwise specified.
实施例1Example 1
本实施例提供了一种制备蛋白结合毒素吸附剂的制备方法,包括如下步骤:This embodiment provides a method for preparing a protein-bound toxin adsorbent, comprising the following steps:
(1)在1000mL三颈烧瓶中加入含2wt%明胶的水溶液600mL,于50℃下搅拌2h,待分散剂明胶完全溶解,依次加入15g氯化钠和10g氯化镁,搅拌使其完全溶解,得到水相;将42g苯乙烯、8g二乙烯苯(简称DVB)、50g甲苯、0.5g过氧化苯甲酰、56g甲基异丁基甲醇(MIBC)混合成油相,将油相缓慢加入水相中,在机械搅拌下,升温至75℃反应5h,再升温至80℃反应5h,再升温至95℃至98℃保温6h至8h,进行悬浮聚合反应使苯乙烯-二乙烯苯共聚物交联固化,并蒸出甲苯,反应结束后,将反应产物依次用水和乙醇洗涤数次,抽滤,干燥,筛分,选取粒径在0.6mm至1.2mm的树脂,即得到低交联苯乙烯-二乙烯苯共聚物。(1) Add 600 mL of an aqueous solution containing 2 wt% gelatin into a 1000 mL three-necked flask, stir at 50° C. for 2 h, and wait until the dispersant gelatin is completely dissolved. Then, add 15 g of sodium chloride and 10 g of magnesium chloride in sequence and stir until they are completely dissolved to obtain an aqueous phase; mix 42 g of styrene, 8 g of divinylbenzene (DVB), 50 g of toluene, 0.5 g of benzoyl peroxide, and 56 g of methyl isobutyl carbinol (MIBC) to form an oil phase, slowly add the oil phase into the aqueous phase, raise the temperature to 75° C. for reaction for 5 h, raise the temperature to 80° C. for reaction for 5 h, and then raise the temperature to 95° C. to 98° C. for insulation for 6 h to 8 h, perform suspension polymerization to crosslink and solidify the styrene-divinylbenzene copolymer, and evaporate toluene. After the reaction is completed, wash the reaction product with water and ethanol several times in sequence, filter, dry, and sieve to select a resin with a particle size of 0.6 mm to 1.2 mm, thereby obtaining a low-crosslinked styrene-divinylbenzene copolymer.
(2)在500mL的三颈烧瓶中加入20g低交联苯乙烯-二乙烯苯共聚物,加入500mL二氯乙烷,常温静置12h充分溶胀;向溶胀后的低交联苯乙烯-二乙烯苯共聚物中依次加入100g氯甲醚和10g无水三氯化铁,开动搅拌器,升温至50℃回流3h,再升温至80℃继续反应7h,再加入5g聚乙烯亚胺,继续在80℃下反应14h,反应结束后冷却至常温,滤出母液,甲醇抽提12h,水洗至无甲醇味,抽滤,干燥得到含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物。(2) Add 20 g of low-crosslinked styrene-divinylbenzene copolymer to a 500 mL three-necked flask, add 500 mL of ethylene dichloride, and let stand at room temperature for 12 h to fully swell; add 100 g of chloromethyl ether and 10 g of anhydrous ferric chloride to the swollen low-crosslinked styrene-divinylbenzene copolymer in sequence, start the stirrer, raise the temperature to 50°C and reflux for 3 h, then raise the temperature to 80°C and continue to react for 7 h, then add 5 g of polyethyleneimine, continue to react at 80°C for 14 h, cool to room temperature after the reaction is completed, filter out the mother liquor, extract with methanol for 12 h, wash with water until there is no methanol smell, filter with suction, and dry to obtain a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine.
(3)取20g含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物,加入140g的硝基苯,在40℃静置溶胀4h,机械搅拌下,加入8g氯化锌,120℃下加热反应8h,氯甲基发生傅克反应形成超高交联网络,反应结束后,降温至常温,滤出母液,用乙醇洗涤至澄清,再用5%的稀盐酸洗涤8h,用乙醇抽提8h,干燥得到超高交联苯乙烯-二乙烯苯树脂,该超高交联苯乙烯-二乙烯苯树脂上固载有聚乙烯亚胺。(3) 20 g of a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine was added to 140 g of nitrobenzene, and the mixture was allowed to swell at 40° C. for 4 h. Under mechanical stirring, 8 g of zinc chloride was added, and the mixture was heated at 120° C. for 8 h. The chloromethyl groups underwent a Friedel-Crafts reaction to form an ultra-high crosslinked network. After the reaction was completed, the mixture was cooled to room temperature, the mother liquor was filtered out, and the mixture was washed with ethanol until clear. The mixture was then washed with 5% dilute hydrochloric acid for 8 h, extracted with ethanol for 8 h, and dried to obtain an ultra-high crosslinked styrene-divinylbenzene resin on which polyethyleneimine was immobilized.
(4)取20g净化后的超高交联苯乙烯-二乙烯苯树脂浸泡至100ml 0.1mol/L的NaOH溶液中,每2h更换一次NaOH溶液直至溶液pH值不变,得到转型后的超高交联苯乙烯-二乙烯苯树脂,将转型后的超高交联苯乙烯-二乙烯苯树脂用去离子水充分清洗,沥干后,将转型后的超高交联苯乙烯-二乙烯苯树脂泡入20wt%布洛芬溶液中24h,浸泡结束后,用去离子水清洗5遍,制得蛋白结合毒素吸附剂。(4) Take 20 g of the purified ultra-high cross-linked styrene-divinylbenzene resin and soak it in 100 ml of 0.1 mol/L NaOH solution. Replace the NaOH solution every 2 hours until the pH value of the solution remains unchanged to obtain the transformed ultra-high cross-linked styrene-divinylbenzene resin. Wash the transformed ultra-high cross-linked styrene-divinylbenzene resin with deionized water. After draining, soak the transformed ultra-high cross-linked styrene-divinylbenzene resin in 20 wt% ibuprofen solution for 24 hours. After soaking, wash it with deionized water 5 times to obtain a protein-bound toxin adsorbent.
实施例2Example 2
本实施例提供了一种制备蛋白结合毒素吸附剂的制备方法,包括如下步骤:This embodiment provides a method for preparing a protein-bound toxin adsorbent, comprising the following steps:
(1)在1000mL三颈烧瓶中加入含2wt%明胶的水溶液600mL,于50℃下搅拌2h,待分散剂明胶完全溶解,依次加入15g氯化钠和10g氯化镁,搅拌使其完全溶解,得到水相;将40g苯乙烯、10g二乙烯苯(简称DVB)、50g甲苯、0.5g过氧化苯甲酰、56g甲基异丁基甲醇(MIBC)混合成油相,将油相缓慢加入水相中,在机械搅拌下,升温至75℃反应5h,再升温至80℃反应5h,再升温至95℃至98℃保温6h至8h,进行悬浮聚合反应使苯乙烯-二乙烯苯共聚物交联固化,并蒸出甲苯,反应结束后,将反应产物依次用水和乙醇洗涤数次,抽滤,干燥,筛分,选取粒径在0.6mm至1.2mm的树脂,即得到低交联苯乙烯-二乙烯苯共聚物。(1) Add 600 mL of an aqueous solution containing 2 wt% gelatin into a 1000 mL three-necked flask, stir at 50° C. for 2 h, and wait until the dispersant gelatin is completely dissolved. Then, add 15 g of sodium chloride and 10 g of magnesium chloride in sequence and stir until they are completely dissolved to obtain an aqueous phase; mix 40 g of styrene, 10 g of divinylbenzene (DVB), 50 g of toluene, 0.5 g of benzoyl peroxide, and 56 g of methyl isobutyl carbinol (MIBC) to form an oil phase, slowly add the oil phase into the aqueous phase, raise the temperature to 75° C. for reaction for 5 h, raise the temperature to 80° C. for reaction for 5 h, and then raise the temperature to 95° C. to 98° C. for insulation for 6 h to 8 h, perform suspension polymerization to crosslink and solidify the styrene-divinylbenzene copolymer, and evaporate toluene. After the reaction is completed, wash the reaction product with water and ethanol several times in sequence, filter, dry, and sieve to select a resin with a particle size of 0.6 mm to 1.2 mm, thereby obtaining a low-crosslinked styrene-divinylbenzene copolymer.
(2)在500mL的三颈烧瓶中加入20g低交联苯乙烯-二乙烯苯共聚物,加入500mL二氯乙烷,常温静置12h充分溶胀;向溶胀后的低交联苯乙烯-二乙烯苯共聚物中依次加入100g氯甲醚和10g无水三氯化铁,开动搅拌器,升温至50℃回流3h,再升温至80℃继续反应7h,再加入10g聚乙烯亚胺,继续在80℃下反应14h,反应结束后冷却至常温,滤出母液,甲醇抽提12h,水洗至无甲醇味,抽滤,干燥得到含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物。(2) Add 20 g of low-crosslinked styrene-divinylbenzene copolymer to a 500 mL three-necked flask, add 500 mL of ethylene dichloride, and let stand at room temperature for 12 h to fully swell; add 100 g of chloromethyl ether and 10 g of anhydrous ferric chloride to the swollen low-crosslinked styrene-divinylbenzene copolymer in sequence, start the stirrer, raise the temperature to 50°C and reflux for 3 h, then raise the temperature to 80°C and continue to react for 7 h, then add 10 g of polyethyleneimine, continue to react at 80°C for 14 h, cool to room temperature after the reaction is completed, filter out the mother liquor, extract with methanol for 12 h, wash with water until there is no methanol smell, filter with suction, and dry to obtain a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine.
(3)取20g含有聚乙烯亚胺的低交联苯乙烯-二乙烯苯共聚物,加入140g的硝基苯,在40℃静置溶胀4h,机械搅拌下,加入8g氯化锌,120℃下加热反应8h,氯甲基发生傅克反应形成超高交联网络,反应结束后,降温至常温,滤出母液,用乙醇洗涤至澄清,再用5%的稀盐酸洗涤8h,用乙醇抽提8h,干燥得到超高交联苯乙烯-二乙烯苯树脂,该超高交联苯乙烯-二乙烯苯树脂上固载有聚乙烯亚胺。(3) 20 g of a low-crosslinked styrene-divinylbenzene copolymer containing polyethyleneimine was added to 140 g of nitrobenzene, and the mixture was allowed to swell at 40° C. for 4 h. Under mechanical stirring, 8 g of zinc chloride was added, and the mixture was heated at 120° C. for 8 h. The chloromethyl groups underwent a Friedel-Crafts reaction to form an ultra-high crosslinked network. After the reaction was completed, the mixture was cooled to room temperature, the mother liquor was filtered out, and the mixture was washed with ethanol until clear. The mixture was then washed with 5% dilute hydrochloric acid for 8 h, extracted with ethanol for 8 h, and dried to obtain an ultra-high crosslinked styrene-divinylbenzene resin on which polyethyleneimine was immobilized.
(4)取20g净化后的超高交联苯乙烯-二乙烯苯树脂浸泡至100ml 0.1mol/L的NaOH溶液中,每2h更换一次NaOH溶液直至溶液pH值不变,得到转型后的超高交联苯乙烯-二乙烯苯树脂,将转型后的超高交联苯乙烯-二乙烯苯树脂用去离子水充分清洗,沥干后,将转型后的超高交联苯乙烯-二乙烯苯树脂泡入30wt%布洛芬溶液中24h,浸泡结束后,用去离子水清洗5遍,制得蛋白结合毒素吸附剂。(4) Take 20 g of the purified ultra-high cross-linked styrene-divinylbenzene resin and soak it in 100 ml of 0.1 mol/L NaOH solution, replace the NaOH solution every 2 hours until the pH value of the solution remains unchanged, and obtain the transformed ultra-high cross-linked styrene-divinylbenzene resin. The transformed ultra-high cross-linked styrene-divinylbenzene resin is thoroughly washed with deionized water, drained, and then soaked in 30 wt% ibuprofen solution for 24 hours. After the soaking, wash it with deionized water 5 times to obtain a protein-bound toxin adsorbent.
对比例1Comparative Example 1
取实施例1的步骤(3)中制备得到的固载有聚乙烯亚胺的超高交联苯乙烯-二乙烯苯树脂作为对比例1中的吸附剂。The ultra-high cross-linked styrene-divinylbenzene resin immobilized with polyethyleneimine prepared in step (3) of Example 1 was used as the adsorbent in Comparative Example 1.
对比例2Comparative Example 2
以市售的健帆生物科技集团股份有限公司生产的HA130血液灌流器中的吸附剂作为对比例2中的吸附剂。The adsorbent in the commercially available HA130 hemoperfusion device produced by Jianfan Biotechnology Group Co., Ltd. was used as the adsorbent in Comparative Example 2.
吸附性能测试:通过外添加法分别配制含IS初始浓度为2.5mg/L的蛋白结合毒素-血浆溶液,含PCS初始浓度为2.5mg/L的蛋白结合毒素-血浆溶液,含IAA初始浓度为0.5mg/L的蛋白结合毒素-血浆溶液;分别取实施例1和实施例2中制得的蛋白结合毒素吸附剂1mL,以及对比例1和对比例2中的吸附剂1mL,分别加入10mL上述三种蛋白结合毒素-血浆溶液中,于37℃的恒温振荡器中以110r/min的速率振荡吸附2h后,分别检测吸附前后不同蛋白结合毒素的浓度,计算不同的吸附剂对不同的蛋白结合毒素的吸附率(例如:在计算对IS的吸附率时,分别取实施例1和实施例2中制得的蛋白结合毒素吸附剂1mL,以及对比例1和对比例2中的吸附剂1mL,分别加入10mL含IS初始浓度为2.5mg/L的蛋白结合毒素-血浆溶液,于37℃的恒温振荡器中以110r/min的速率振荡吸附2h后,分别检测吸附前后IS的浓度,计算不同的吸附剂对IS的吸附率)。其中,IS,PCS和IAA的浓度通过HPLC分析方法进行检测得到,Adsorption performance test: A protein-bound toxin-plasma solution containing an initial concentration of IS of 2.5 mg/L, a protein-bound toxin-plasma solution containing an initial concentration of PCS of 2.5 mg/L, and a protein-bound toxin-plasma solution containing an initial concentration of IAA of 0.5 mg/L were prepared by an external addition method; 1 mL of the protein-bound toxin adsorbent prepared in Example 1 and Example 2, and 1 mL of the adsorbent in Comparative Example 1 and Comparative Example 2 were taken, respectively, and added to 10 mL of the above three protein-bound toxin-plasma solutions, and oscillated at a rate of 110 r/min in a constant temperature oscillator at 37°C for 2 h for adsorption. After that, the concentrations of different protein-bound toxins before and after adsorption were detected, and the adsorption rates of different adsorbents for different protein-bound toxins were calculated (for example: when calculating the adsorption rate for IS, 1 mL of the protein-bound toxin adsorbents prepared in Example 1 and Example 2, and 1 mL of the adsorbents in Comparative Examples 1 and 2 were taken, and 10 mL of protein-bound toxin-plasma solution containing an initial IS concentration of 2.5 mg/L was added, respectively, and adsorbed at a rate of 110 r/min in a constant temperature oscillator at 37°C for 2 hours, and then the concentrations of IS before and after adsorption were detected, and the adsorption rates of different adsorbents for IS were calculated). Wherein, the concentrations of IS, PCS and IAA were detected by HPLC analysis method,
吸附率的计算公式为:Cr(%)=(C0-Ct)/C0×100%,其中,Cr为目标蛋白结合毒素的浓度下降率,C0为吸附前目标蛋白结合毒素的检测浓度,Ct为吸附2h后目标蛋白结合毒素的检测浓度。各实施例、对比例1和对比例2中的吸附剂对各个蛋白结合毒素的吸附率如表1所示。The calculation formula of adsorption rate is: Cr (%) = (C0-Ct) / C0 × 100%, where Cr is the concentration decrease rate of the target protein-bound toxin, C0 is the detection concentration of the target protein-bound toxin before adsorption, and Ct is the detection concentration of the target protein-bound toxin after 2 hours of adsorption. The adsorption rates of the adsorbents in each embodiment, comparative example 1 and comparative example 2 for each protein-bound toxin are shown in Table 1.
表1Table 1
由表1可以看出,实施例1和实施例2中的蛋白结合毒素吸附剂与对比例1和对比例2中的吸附剂相比,对IS、PCS和IAA的吸附性能显著提升,说明本发明中提供的蛋白结合毒素吸附剂对蛋白结合毒素具有更优异的清除效果,尤其是对IS、PCS和IAA具有优异的清除效果。此外,本发明提供的蛋白结合毒素吸附剂还具有良好的安全性能和优异的力学强度,能够满足全血灌流需求。As can be seen from Table 1, the protein-bound toxin adsorbents in Example 1 and Example 2 have significantly improved adsorption performance for IS, PCS and IAA compared to the adsorbents in Comparative Examples 1 and 2, indicating that the protein-bound toxin adsorbent provided in the present invention has a better removal effect on protein-bound toxins, especially for IS, PCS and IAA. In addition, the protein-bound toxin adsorbent provided by the present invention also has good safety performance and excellent mechanical strength, and can meet the needs of whole blood perfusion.
虽然本公开披露如上,但本公开的保护范围并非仅限于此。本领域技术人员在不脱离本公开的精神和范围的前提下,可进行各种变更与修改,这些变更与修改均将落入本发明的保护范围。Although the disclosure is disclosed as above, the protection scope of the disclosure is not limited thereto. Those skilled in the art may make various changes and modifications without departing from the spirit and scope of the disclosure, and these changes and modifications will fall within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410483702.3A CN118384862A (en) | 2024-04-22 | 2024-04-22 | Protein-bound toxin adsorbent and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410483702.3A CN118384862A (en) | 2024-04-22 | 2024-04-22 | Protein-bound toxin adsorbent and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118384862A true CN118384862A (en) | 2024-07-26 |
Family
ID=91984040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410483702.3A Pending CN118384862A (en) | 2024-04-22 | 2024-04-22 | Protein-bound toxin adsorbent and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118384862A (en) |
-
2024
- 2024-04-22 CN CN202410483702.3A patent/CN118384862A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105418946B (en) | The preparation method of secondary cross-linking polymeric adsorbent | |
US6087300A (en) | Method of producing material for purification of physiological liquids of organism | |
CN105085829B (en) | The preparation method of the macroporous absorbent resin adsorbed for toxic substance | |
CN104174385B (en) | A kind of adsorbent for bilirubin for blood perfusion | |
CN104492402A (en) | Preparation method of adsorbent for adsorbing low-density lipoprotein (LDL) for whole blood perfusion | |
CN104525155B (en) | Adsorbent used for absorbing low density lipoprotein (LDL) in whole blood perfusion and preparation method of adsorbent | |
CN108371945A (en) | For in removing in uremic patient body, the adsorbent of macromolecular toxins and preparation method | |
WO2022147847A1 (en) | Adsorbent for removing protein-bound uremic toxins by means of blood perfusion and preparation method therefor | |
CN114106407B (en) | Blood perfusion adsorbent and preparation method thereof | |
CN105561950A (en) | Macroreticular resin and preparing method thereof | |
CN114288998A (en) | Adsorption resin and preparation method and application thereof | |
CN113509919B (en) | An adsorbent that can be used to remove endotoxin and inflammatory factors in the blood of patients with sepsis and its preparation method | |
JP4879018B2 (en) | Polyether separation matrix and separation method | |
CN109734839B (en) | A kind of high anticoagulation polystyrene microsphere and its preparation method and application | |
CN110215911A (en) | A kind of preparation method of modified boehmite adsorbed film | |
CN118384862A (en) | Protein-bound toxin adsorbent and preparation method and application thereof | |
CN106140110A (en) | A kind of preparation method of low density lipoprotein, LDL adsorbent | |
CN114452952B (en) | Ultrahigh crosslinked adsorption resin with bimodal pore structure, and preparation method and application thereof | |
CN114405488A (en) | Protein-bound toxoid blood perfusion adsorbent and preparation method and application thereof | |
CN114288997A (en) | Adsorption resin with self-anticoagulation property and preparation method and application thereof | |
CN114907610A (en) | Preparation method of porous polymer microsphere oil removing resin | |
CN108246264B (en) | A kind of DNA immunoadsorbent and preparation method thereof | |
CN113262762A (en) | Adsorbing material for blood perfusion and preparation method thereof | |
CN117504834A (en) | Adsorbent for removing myoglobin and preparation method thereof | |
CN114797800B (en) | Adsorbent for removing toxin in body of uremia patient and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |